$30.30
+0.280 (+0.93%)
At Close: Jun 03, 2026
Best Momentum Stock to Buy for August 8th
11:01am, Friday, 08'th Aug 2025
RIGL, APG and CLSK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 8, 2025.
5 Best Stocks With Relative Price Strength to Buy Right Now
10:15am, Friday, 08'th Aug 2025
LendingTree, RIGL, and others are standing out with strong relative price strength amid market volatility.
New Strong Buy Stocks for August 8th
07:10am, Friday, 08'th Aug 2025
INFU, RIGL, TROW, MITSY and NTRS have been added to the Zacks Rank #1 (Strong Buy) List on August 8, 2025.
Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy?
10:55am, Thursday, 07'th Aug 2025
From a technical perspective, Rigel Pharmaceuticals, Inc. (RIGL) is looking like an interesting pick, as it just reached a key level of support. RIGL's 50-day simple moving average crossed above its 2
Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run?
10:16am, Thursday, 07'th Aug 2025
Rigel (RIGL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Rigel (RIGL) Q2 Revenue Jumps 176%
07:19am, Wednesday, 06'th Aug 2025
Rigel (RIGL) Q2 Revenue Jumps 176%
Rigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call Transcript
08:02pm, Tuesday, 05'th Aug 2025
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants David A. Santos - Executive VP & Chief Commercial Officer Dean L.
Rigel Pharmaceuticals (RIGL) Q2 Earnings and Revenues Surpass Estimates
07:10pm, Tuesday, 05'th Aug 2025
Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $3.28 per share, beating the Zacks Consensus Estimate of $1.97 per share. This compares to a loss of $0.06 per share a year ago.
Rigel Reports Second Quarter 2025 Financial Results and Provides Business Update
04:01pm, Tuesday, 05'th Aug 2025
Second quarter 2025 total revenue of approximately $101.7 million, which includes net product sales of $58.9 million and contract revenues from collaborations of $42.7 million Completed enrollment i
Why Rigel (RIGL) Could Beat Earnings Estimates Again
01:11pm, Wednesday, 30'th Jul 2025
Rigel (RIGL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Can Rigel (RIGL) Climb 69.55% to Reach the Level Wall Street Analysts Expect?
10:55am, Wednesday, 30'th Jul 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 69.6% in Rigel (RIGL). While the effectiveness of this highly sought-after metric is questionable, the positive
Are Investors Undervaluing Rigel Pharmaceuticals (RIGL) Right Now?
10:41am, Wednesday, 30'th Jul 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Rigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business Update
08:05am, Tuesday, 29'th Jul 2025
SOUTH SAN FRANCISCO, Calif. , July 29, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its second quarter 2025 financial results after market close
Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
08:05am, Monday, 07'th Jul 2025
SOUTH SAN FRANCISCO, Calif. , July 7, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc. I
Is Rigel Pharmaceuticals (RIGL) Stock Undervalued Right Now?
10:46am, Thursday, 29'th May 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Sign In
Buy RIGL